HomeNewsIndiaSEBI feels mutual funds have full flexibility on PTCs, no further relaxations needed

SEBI feels mutual funds have full flexibility on PTCs, no further relaxations needed

PTCs are certificates given to the investors including banks and mutual funds, where repayment comes from a basket or pool of underlying loans, usually loans taken by individuals.

April 12, 2020 / 15:02 IST

In the wake of the COVID-19 crisis, mutual funds have been given a number of relaxations by regulator Sebi and they have got full flexibility regarding the valuation of Pass-Through Certificates including in case of the moratorium on underlying loans, officials said on Sunday. PTCs are certificates given to the investors including banks and mutual funds, where repayment comes from a basket or pool of underlying loans, usually loans taken by individuals. PTCs are usually issued by NBFCs, through a trust structure.

Officials said the fund houses already have sufficient flexibility under various Sebi regulations on valuation of PTCs and therefore no further relaxations are required to deal with the moratorium situation arising out of the COVID-19 crisis.

Recently, the industry body of mutual funds, the Association of Mutual Funds in India (AMFI), had written to Sebi regarding relaxation relating to valuation of PTCs if underlying loans are given a moratorium.

"On account of COVID related disruption, there is apprehension that there could be defaults in payment of interest or principal to the investors who have bought PTCs since interest and principal payments on PTCs is dependent on cash flows from the underlying loan pools," a senior official of an Asset Management Company (AMC) said.

"RBI has given banks permission to give moratorium to their borrowers. In this context, NBFCs have sought permission from the investors of PTCs also to grant moratorium to the borrowers of the underlying loans,” the AMC official added.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

As per mutual fund regulations, any restructuring or moratorium type deferment of dues would mean that valuation agencies have to treat such securities as default and value them accordingly.

This regulation was brought in to ensure that NAVs of schemes are not inflated thereby permitting informed investors to exit at high NAV, leaving small retail investors with assets which may subsequently go bad, a market expert said.

However, since AMCs have the final responsibility of fair valuation of their schemes, Sebi regulations permit AMCs to deviate from the valuation given by the valuation agencies and determine their own fair valuation provided they take approval of the AMC Board and Trustees and disclose the same on their websites, an official said.

The Securities and Exchange Board of India (Sebi) is understood to have taken a view that "mutual funds already have full flexibility in valuation of PTCs in all scenarios including if moratorium is given to the underlying loans".

"Existing guidelines already have provisions for mutual funds to deviate from the valuation given by the valuation agencies," the official added.

Moreover, different mutual funds may have different circumstances in relation to their investments in PTCs. Thus, mutual funds should have the flexibility to take their independent decisions in the best interest of their unit holders.

"Some mutual funds may also choose to put such PTCs into a segregated portfolio as permitted by Sebi regulations if they feel that that is in the best interest of their unit holders," a market observer said.

While PTCs are generally housed in debt schemes, mutual funds have been experiencing good inflows into equity schemes, as shown by figures for March, despite a market sell-off, as per the AMFI figures.

PTI
first published: Apr 12, 2020 02:58 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347